Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
The study is designed to determine if the administration of multi-drug adjuvant chemotherapy
for patients with primary non-metastatic osteogenic sarcoma, both prior to and after the
definitive surgical procedure for their primary tumor is superior as a treatment strategy to
the current approach of giving drugs only after the definitive surgical procedure has been
performed. An effort will be made as well to determine if the administration of
pre-definitive surgery, chemotherapy leads to an increase in the proportion of the patients
suitable for a limb salvage primary surgical procedure.
Interventional
Endpoint Classification: Efficacy Study, Primary Purpose: Treatment
United States: Federal Government
870068
NCT00001217
May 1987
December 2000
Name | Location |
---|---|
National Cancer Institute (NCI) | Bethesda, Maryland 20892 |